275 related articles for article (PubMed ID: 38445632)
1. Understanding the molecular mechanism responsible for developing therapeutic radiation-induced radioresistance of rectal cancer and improving the clinical outcomes of radiotherapy - A review.
Jain SM; Nagainallur Ravichandran S; Murali Kumar M; Banerjee A; Sun-Zhang A; Zhang H; Pathak R; Sun XF; Pathak S
Cancer Biol Ther; 2024 Dec; 25(1):2317999. PubMed ID: 38445632
[TBL] [Abstract][Full Text] [Related]
2. XRCC2 as a predictive biomarker for radioresistance in locally advanced rectal cancer patients undergoing preoperative radiotherapy.
Qin CJ; Song XM; Chen ZH; Ren XQ; Xu KW; Jing H; He YL
Oncotarget; 2015 Oct; 6(31):32193-204. PubMed ID: 26320178
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of nuclear β-catenin in rectal adenocarcinoma is associated with radioresistance.
Wang L; Zhang XM; Li Z; Liu XJ; Chai J; Zhang GY; Cheng YF
World J Gastroenterol; 2013 Oct; 19(40):6876-82. PubMed ID: 24187464
[TBL] [Abstract][Full Text] [Related]
4. CSC Radioresistance: A Therapeutic Challenge to Improve Radiotherapy Effectiveness in Cancer.
Olivares-Urbano MA; Griñán-Lisón C; Marchal JA; Núñez MI
Cells; 2020 Jul; 9(7):. PubMed ID: 32660072
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia Modulates Radiosensitivity and Response to Different Radiation Qualities in A549 Non-Small Cell Lung Cancer (NSCLC) Cells.
Nisar H; Labonté FM; Roggan MD; Schmitz C; Chevalier F; Konda B; Diegeler S; Baumstark-Khan C; Hellweg CE
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256084
[TBL] [Abstract][Full Text] [Related]
6. Targeting PI3K/Akt/mTOR signaling pathway in the treatment of prostate cancer radioresistance.
Chang L; Graham PH; Ni J; Hao J; Bucci J; Cozzi PJ; Li Y
Crit Rev Oncol Hematol; 2015 Dec; 96(3):507-17. PubMed ID: 26253360
[TBL] [Abstract][Full Text] [Related]
7. Phosphatidylinositol 3-kinase/Akt signaling as a key mediator of tumor cell responsiveness to radiation.
Toulany M; Rodemann HP
Semin Cancer Biol; 2015 Dec; 35():180-90. PubMed ID: 26192967
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of microRNA action in rectal cancer radiotherapy.
Zhu L; Wang M; Chen N; Zhang Y; Xu T; Zhuang W; Xiao S; Dai L
Chin Med J (Engl); 2022 Sep; 135(17):2017-2025. PubMed ID: 35943251
[TBL] [Abstract][Full Text] [Related]
9. DSTN Hypomethylation Promotes Radiotherapy Resistance of Rectal Cancer by Activating the Wnt/β-Catenin Signaling Pathway.
Wen R; Zhou L; Jiang S; Fan H; Zheng K; Yu Y; Gao X; Hao L; Lou Z; Yu G; Yang F; Zhang W
Int J Radiat Oncol Biol Phys; 2023 Sep; 117(1):198-210. PubMed ID: 37019366
[TBL] [Abstract][Full Text] [Related]
10. Cell cultures in assessing radioresistance of glioblastomas.
Belyashova AS; Galkin MV; Antipina NA; Pavlova GV; Golanov AV
Zh Vopr Neirokhir Im N N Burdenko; 2022; 86(5):126-132. PubMed ID: 36252203
[TBL] [Abstract][Full Text] [Related]
11. The Role of EphA4 Signaling in Radiation-Induced EMT-Like Phenotype in Colorectal Cancer Cells.
de Marcondes PG; Morgado-Díaz JA
J Cell Biochem; 2017 Mar; 118(3):442-445. PubMed ID: 27632701
[TBL] [Abstract][Full Text] [Related]
12. Enhancing radiotherapy outcomes in rectal cancer: A systematic review of targeting hypoxia-induced radioresistance.
Fok M; Hill R; Fowler H; Clifford R; Kler A; Uzzi-Daniel J; Rocha S; Grundy G; Parsons J; Vimalachandran D
Clin Transl Radiat Oncol; 2024 Jan; 44():100695. PubMed ID: 37961749
[TBL] [Abstract][Full Text] [Related]
13. The mechanisms and reversal strategies of tumor radioresistance in esophageal squamous cell carcinoma.
Zhang H; Si J; Yue J; Ma S
J Cancer Res Clin Oncol; 2021 May; 147(5):1275-1286. PubMed ID: 33687564
[TBL] [Abstract][Full Text] [Related]
14. Exosome-Mediated Transfer of miR-1323 from Cancer-Associated Fibroblasts Confers Radioresistance of C33A Cells by Targeting PABPN1 and Activating Wnt/β-Catenin Signaling Pathway in Cervical Cancer.
Fang F; Guo C; Zheng W; Wang Q; Zhou L
Reprod Sci; 2022 Jun; 29(6):1809-1821. PubMed ID: 35334101
[TBL] [Abstract][Full Text] [Related]
15. Preoperative radiotherapy and curative surgery for the management of localised rectal carcinoma.
Abraha I; Aristei C; Palumbo I; Lupattelli M; Trastulli S; Cirocchi R; De Florio R; Valentini V
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD002102. PubMed ID: 30284239
[TBL] [Abstract][Full Text] [Related]
16. Augmenting the therapeutic window of radiotherapy: A perspective on molecularly targeted therapies and nanomaterials.
Reda M; Bagley AF; Zaidan HY; Yantasee W
Radiother Oncol; 2020 Sep; 150():225-235. PubMed ID: 32598976
[TBL] [Abstract][Full Text] [Related]
17. Human phosphatidylethanolamine-binding protein 4 promoted the radioresistance of human rectal cancer by activating Akt in an ROS-dependent way.
Qiu J; Yang G; Lin A; Shen Z; Wang D; Ding L
PLoS One; 2014; 9(3):e90062. PubMed ID: 24594691
[TBL] [Abstract][Full Text] [Related]
18. Novel insight into metabolic reprogrammming in cancer radioresistance: A promising therapeutic target in radiotherapy.
Yu Y; Yu J; Ge S; Su Y; Fan X
Int J Biol Sci; 2023; 19(3):811-828. PubMed ID: 36778122
[TBL] [Abstract][Full Text] [Related]
19. Tumor suppressor miR-29c regulates radioresistance in lung cancer cells.
Arechaga-Ocampo E; Lopez-Camarillo C; Villegas-Sepulveda N; Gonzalez-De la Rosa CH; Perez-Añorve IX; Roldan-Perez R; Flores-Perez A; Peña-Curiel O; Angeles-Zaragoza O; Rangel Corona R; Gonzalez-Barrios JA; Bonilla-Moreno R; Del Moral-Hernandez O; Herrera LA; Garcia-Carranca A
Tumour Biol; 2017 Mar; 39(3):1010428317695010. PubMed ID: 28345453
[TBL] [Abstract][Full Text] [Related]
20. Wnt/β-catenin inhibitor ICG-001 enhances the antitumor efficacy of radiotherapy by increasing radiation-induced DNA damage and improving tumor immune microenvironment in hepatocellular carcinoma.
Huang Y; Sheng H; Xiao Y; Hu W; Zhang Z; Chen Y; Zhu Z; Wu D; Cao C; Sun J
Radiother Oncol; 2021 Sep; 162():34-44. PubMed ID: 34214613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
